logo


Currently fear rules credit markets with the market being virtually frozen for all credits except a few that are either government owned or having extremely strong fundamentals. FeRead More
FIIs/FPIs have bought Indian equity shares worth Rs. 211 billion in April 2019 and sold shares worth Rs. 20 billion in May 2019 (till 24th May 2019). The Nifty Index futures witnesRead More
The election victory for the ruling NDA party has taken out political risk from bond markets and also ensures continuity of fiscal policy, as laid out in the interim budget for fisRead More
“Strong Core” 12 Stock Portfolio Changes: We exited Ajanta Pharma at Rs. 1028, which has given -18% returns in our “Strong Core”  12 Stock since recommendatRead More
Dear Advisory Client, The 5 year mandate to the NDA government takes out political risks from the markets but given a faltering economy, equities will continue to witness a narrow Read More
Results Update This Company has reported results for the quarter ended  March 2019. The revenue growth has decreased in lower single digits as compared to the previous year same quRead More
  CLICK HERE TO READ OUR COMPLETE ANALYSISRead More
Stocks will take one year to stabilize, good time to accumulate Equity markets will stabilize at higher levels and take direction from earnings outlook, economy and global issues. Read More
Election results on 23rd May 2019 have a lot of significance to markets and your investments. Arjun Parthasarathy will take all your questions on the markets at 2:30 pm on the 23rdRead More
The 4th quarter Fy 19 results and management guidance point to a slowdown in demand and headwinds across many sectors. The NBFC liquidity crisis is also weighing on financial sectoRead More
This Financial Services stock in our “Strong Core” Portfolios has delivered exceptional performance for the fourth quarter of FY 19. The company’s Assets under MaRead More
FIIs/FPIs have bought Indian equity shares worth Rs. 211 billion in April 2019 and sold shares worth Rs. 48 billion in May 2019 (till 17th May 2019). The Nifty Index futures witnesRead More
Election results will drive bond yields this week. The biggest risk for bond yields is an opposition win, as implementation of NYAY can cause a huge hole in the fiscal. The NYAY wiRead More
We recommend our clients to exit Ajanta Pharma. Although, the company has a limited exposure to US pharma market, the industry is facing Quality & Legal Risks, which threatens Read More
Investors in Indian pharma companies  have seen large falls in values of top pharma companies on the back of US FDA observations on the manufacturing facilities. There are now moreRead More

Top